• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生障碍性贫血的抗淋巴细胞球蛋白治疗——一所大学医院的经验

Anti-lymphocyte globulin therapy in aplastic anaemia--a university hospital experience.

作者信息

Leong K W, Teh A, Bosco J J, Jayaranee S, Sadat U

机构信息

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur.

出版信息

Med J Malaysia. 1995 Jun;50(2):158-61.

PMID:7565186
Abstract

Antilymphocyte globulin (ALG) was given every other day for 5 doses with platelet transfusions immediately following ALG administration in 6 patients with aplastic anaemia. Four patients responded and 3 durable remissions were achieved. One patient relapsed and further treatment with anti-thymocyte globulin and cyclosporin also failed. One patient died of Flavobacterium septicaemia 6 days after completion of ALG. Our data suggests that using an alternate day regimen, a response rate similar to a daily regimen can be obtained.

摘要

对6例再生障碍性贫血患者每隔一天给予抗淋巴细胞球蛋白(ALG),共5剂,并在给予ALG后立即输注血小板。4例患者有反应,3例获得持久缓解。1例患者复发,使用抗胸腺细胞球蛋白和环孢素进一步治疗也失败。1例患者在完成ALG治疗6天后死于弗氏杆菌败血症。我们的数据表明,采用隔日给药方案可获得与每日给药方案相似的反应率。

相似文献

1
Anti-lymphocyte globulin therapy in aplastic anaemia--a university hospital experience.再生障碍性贫血的抗淋巴细胞球蛋白治疗——一所大学医院的经验
Med J Malaysia. 1995 Jun;50(2):158-61.
2
Anti-lymphocyte globulin therapy in acquired aplastic anaemia.
J Assoc Physicians India. 1993 Jun;41(6):371-3.
3
[Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].抗胸腺细胞/抗淋巴细胞球蛋白对重型再生障碍性贫血及治疗相关并发症的治疗作用
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Dec;8(6):479-81.
4
[Antilymphocyte globulin in the treatment of aplastic anemia].[抗淋巴细胞球蛋白治疗再生障碍性贫血]
Med Pregl. 1993;46(7-8):291-5.
5
Factors influencing platelet survival during antilymphocyte globulin treatment.抗淋巴细胞球蛋白治疗期间影响血小板存活的因素。
Br J Haematol. 1984 May;57(1):5-15.
6
Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.抗淋巴细胞球蛋白、环孢素及两种不同粒细胞集落刺激因子方案治疗重型再生障碍性贫血:一项GITMO前瞻性随机研究
Haematologica. 2004 Sep;89(9):1054-61.
7
[Heteroimmune hemolytic anemia associated with antilymphocyte globulin treatment in a patient with aplastic anemia].
Medicina (B Aires). 1990;50(4):361-4.
8
[Adverse effects of anti-thymocyte globulin/anti-lymphocyte globulin therapy].[抗胸腺细胞球蛋白/抗淋巴细胞球蛋白治疗的不良反应]
Rinsho Ketsueki. 1999 Jul;40(7):531-5.
9
[Acute monocytic leukemia following anti-lymphocyte immunoglobulin treatment in a patient with severe aplastic anemia].[严重再生障碍性贫血患者接受抗淋巴细胞免疫球蛋白治疗后发生急性单核细胞白血病]
Rinsho Ketsueki. 1993 May;34(5):673-5.
10
[Immunomodulating treatment of severe aplastic anemia in adults].[成人重型再生障碍性贫血的免疫调节治疗]
Tidsskr Nor Laegeforen. 1993 Apr 30;113(11):1351-4.

引用本文的文献

1
Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.获得性再生障碍性贫血及免疫介导的骨髓衰竭综合征的免疫抑制治疗
Int J Hematol. 2002 Feb;75(2):129-40. doi: 10.1007/BF02982017.